中医药治疗乳腺癌进展  

Research Progress of Traditional Chinese Medicine Treatment of Breast Cancer

作　　者：周思颖[1] 张思杰[2] 徐寒子[3] 孙大伟 唐金海[1,5] 

机构地区：[1]南京中医药大学第一临床医学院,南京210023 [2]南京中医药大学附属苏州市中医医院,苏州215000 [3]南京医科大学附属江苏省肿瘤医院放疗科,南京210000 [4]南京医科大学附属江苏省肿瘤医院普外科,南京210000 [5]江苏省人民医院,南京210000

出　　处：《中国中医基础医学杂志》2017年第10期1489-1492,共4页JOURNAL OF BASIC CHINESE MEDICINE

基　　金：国家自然科学基金资助项目(81272470)-微泡介导的细胞间miRNA传递在乳腺癌耐药形成中的作用及其机制研究

摘　　要：近年来中医药在乳腺癌综合治疗中发挥了独特作用并有重要地位。此综述回顾总结了中医对乳腺癌病因病机的认识,将中医辨证论治与疾病分期及诊疗技术相结合,拓展中医理论内涵,丰富乳腺癌中西医结合理论基础。介绍了中医药的实际临床应用及疗效,如改善术后并发症、对抗化疗耐药性、降低放化疗副反应、减轻内分泌治疗的副作用、提高生活质量及延长生存期等方面,通过对中医药干预乳腺癌的实验室研究,进一步证实了中医药多途径、多靶点的药用特点。Traditional Chinese medicine（TCM） has played a unique role in comprehensive therapy of breast cancer in recent years. In this review, through a clear understanding of breast cancer etiology and pathogenesis of TCM, we associated syndrome differentiation of TCM with disease staging and diagnostic technology, which is not only beneficial of expanding the theory meaning of TCM but is also of great significance to abundant theoretical basis of Chinese and western medicine in the treatment of breast cancer. We also introduced actual clinical application and efficacy of TCM, such as improving the postoperative complications, playing a role against drug resistance of chemotherapy, reducing the radiation and chemotherapy side effects, reducing the side effect of hormone therapy, improving the quality of life and prolonging survival etc. Through the laboratory research of TCM intervention in breast cancer, we also confirmed that TCM has the characteristic of multi-pathway and multi-target.

关 键 词：乳腺癌 中医药 中西医结合 综述 

分 类 号：R271.44[医药卫生—中医妇科学]